A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder

Joseph Biederman, Frank A. Lopez, Samuel W. Boellner, Mark C. Chandler

Research output: Contribution to journal › Article › peer-review

163 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder'. Together they form a unique fingerprint.

Medicine & Life Sciences